Ron Leuty of the San Francisco Business Times has a feature on Genentech’s “4HER” app for women diagnosed with HER2-positive breast cancer:
“Over years of cancer drug research, Genentech Inc. has kept a keen watch on patients: how they respond to drugs in a clinical trial, for example, or what patients need in a next-generation drug. Yet even as the South San Francisco-based biotech unit of Swiss drug giant Roche developed some of the best-selling and effective cancer drugs — Avastin and Herceptin among them — it heard from patients that the medications themselves were not enough.
Breast cancer patients, in particular, wanted to feel connected to others going through treatment. They wanted more support and resources. So Genentech created its own smartphone app to help breast cancer patients understand more about their disease, its treatment and other resources available to them.”